Global Crysvita Injection Market Growth 2022-2028
- LP 4980668
- 75 Pages
- August 2022
- Pharmaceuticals
The United States Crysvita Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Crysvita Injection market, reaching US$ million by the year 2028. As for the Europe Crysvita Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Crysvita Injection players cover Kyowa Kirin, Ultragenyx Pharmaceutical, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Crysvita Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
10 mg/mL
20 mg/mL
30 mg/mL
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Children
Adults
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Kyowa Kirin
Ultragenyx Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Crysvita Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Crysvita Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Crysvita Injection by Country/Region, 2017, 2022 & 2028
2.2 Crysvita Injection Segment by Type
2.2.1 10 mg/mL
2.2.2 20 mg/mL
2.2.3 30 mg/mL
2.3 Crysvita Injection Sales by Type
2.3.1 Global Crysvita Injection Sales Market Share by Type (2017-2022)
2.3.2 Global Crysvita Injection Revenue and Market Share by Type (2017-2022)
2.3.3 Global Crysvita Injection Sale Price by Type (2017-2022)
2.4 Crysvita Injection Segment by Application
2.4.1 Children
2.4.2 Adults
2.5 Crysvita Injection Sales by Application
2.5.1 Global Crysvita Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Crysvita Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Crysvita Injection Sale Price by Application (2017-2022)
3 Global Crysvita Injection by Company
3.1 Global Crysvita Injection Breakdown Data by Company
3.1.1 Global Crysvita Injection Annual Sales by Company (2020-2022)
3.1.2 Global Crysvita Injection Sales Market Share by Company (2020-2022)
3.2 Global Crysvita Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Crysvita Injection Revenue by Company (2020-2022)
3.2.2 Global Crysvita Injection Revenue Market Share by Company (2020-2022)
3.3 Global Crysvita Injection Sale Price by Company
3.4 Key Manufacturers Crysvita Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Crysvita Injection Product Location Distribution
3.4.2 Players Crysvita Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Crysvita Injection by Geographic Region
4.1 World Historic Crysvita Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Crysvita Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Crysvita Injection Annual Revenue by Geographic Region
4.2 World Historic Crysvita Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Crysvita Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Crysvita Injection Annual Revenue by Country/Region
4.3 Americas Crysvita Injection Sales Growth
4.4 APAC Crysvita Injection Sales Growth
4.5 Europe Crysvita Injection Sales Growth
4.6 Middle East & Africa Crysvita Injection Sales Growth
5 Americas
5.1 Americas Crysvita Injection Sales by Country
5.1.1 Americas Crysvita Injection Sales by Country (2017-2022)
5.1.2 Americas Crysvita Injection Revenue by Country (2017-2022)
5.2 Americas Crysvita Injection Sales by Type
5.3 Americas Crysvita Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Crysvita Injection Sales by Region
6.1.1 APAC Crysvita Injection Sales by Region (2017-2022)
6.1.2 APAC Crysvita Injection Revenue by Region (2017-2022)
6.2 APAC Crysvita Injection Sales by Type
6.3 APAC Crysvita Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Crysvita Injection by Country
7.1.1 Europe Crysvita Injection Sales by Country (2017-2022)
7.1.2 Europe Crysvita Injection Revenue by Country (2017-2022)
7.2 Europe Crysvita Injection Sales by Type
7.3 Europe Crysvita Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Crysvita Injection by Country
8.1.1 Middle East & Africa Crysvita Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Crysvita Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Crysvita Injection Sales by Type
8.3 Middle East & Africa Crysvita Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Crysvita Injection
10.3 Manufacturing Process Analysis of Crysvita Injection
10.4 Industry Chain Structure of Crysvita Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Crysvita Injection Distributors
11.3 Crysvita Injection Customer
12 World Forecast Review for Crysvita Injection by Geographic Region
12.1 Global Crysvita Injection Market Size Forecast by Region
12.1.1 Global Crysvita Injection Forecast by Region (2023-2028)
12.1.2 Global Crysvita Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Crysvita Injection Forecast by Type
12.7 Global Crysvita Injection Forecast by Application
13 Key Players Analysis
13.1 Kyowa Kirin
13.1.1 Kyowa Kirin Company Information
13.1.2 Kyowa Kirin Crysvita Injection Product Offered
13.1.3 Kyowa Kirin Crysvita Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Kyowa Kirin Main Business Overview
13.1.5 Kyowa Kirin Latest Developments
14 Research Findings and Conclusion
Table 1. Crysvita Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Crysvita Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 10 mg/mL
Table 4. Major Players of 20 mg/mL
Table 5. Major Players of 30 mg/mL
Table 6. Global Crysvita Injection Sales by Type (2017-2022) & (K Units)
Table 7. Global Crysvita Injection Sales Market Share by Type (2017-2022)
Table 8. Global Crysvita Injection Revenue by Type (2017-2022) & ($ million)
Table 9. Global Crysvita Injection Revenue Market Share by Type (2017-2022)
Table 10. Global Crysvita Injection Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Crysvita Injection Sales by Application (2017-2022) & (K Units)
Table 12. Global Crysvita Injection Sales Market Share by Application (2017-2022)
Table 13. Global Crysvita Injection Revenue by Application (2017-2022)
Table 14. Global Crysvita Injection Revenue Market Share by Application (2017-2022)
Table 15. Global Crysvita Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Crysvita Injection Sales by Company (2020-2022) & (K Units)
Table 17. Global Crysvita Injection Sales Market Share by Company (2020-2022)
Table 18. Global Crysvita Injection Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Crysvita Injection Revenue Market Share by Company (2020-2022)
Table 20. Global Crysvita Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Crysvita Injection Producing Area Distribution and Sales Area
Table 22. Players Crysvita Injection Products Offered
Table 23. Crysvita Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Crysvita Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Crysvita Injection Sales Market Share Geographic Region (2017-2022)
Table 28. Global Crysvita Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Crysvita Injection Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Crysvita Injection Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Crysvita Injection Sales Market Share by Country/Region (2017-2022)
Table 32. Global Crysvita Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Crysvita Injection Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Crysvita Injection Sales by Country (2017-2022) & (K Units)
Table 35. Americas Crysvita Injection Sales Market Share by Country (2017-2022)
Table 36. Americas Crysvita Injection Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Crysvita Injection Revenue Market Share by Country (2017-2022)
Table 38. Americas Crysvita Injection Sales by Type (2017-2022) & (K Units)
Table 39. Americas Crysvita Injection Sales Market Share by Type (2017-2022)
Table 40. Americas Crysvita Injection Sales by Application (2017-2022) & (K Units)
Table 41. Americas Crysvita Injection Sales Market Share by Application (2017-2022)
Table 42. APAC Crysvita Injection Sales by Region (2017-2022) & (K Units)
Table 43. APAC Crysvita Injection Sales Market Share by Region (2017-2022)
Table 44. APAC Crysvita Injection Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Crysvita Injection Revenue Market Share by Region (2017-2022)
Table 46. APAC Crysvita Injection Sales by Type (2017-2022) & (K Units)
Table 47. APAC Crysvita Injection Sales Market Share by Type (2017-2022)
Table 48. APAC Crysvita Injection Sales by Application (2017-2022) & (K Units)
Table 49. APAC Crysvita Injection Sales Market Share by Application (2017-2022)
Table 50. Europe Crysvita Injection Sales by Country (2017-2022) & (K Units)
Table 51. Europe Crysvita Injection Sales Market Share by Country (2017-2022)
Table 52. Europe Crysvita Injection Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Crysvita Injection Revenue Market Share by Country (2017-2022)
Table 54. Europe Crysvita Injection Sales by Type (2017-2022) & (K Units)
Table 55. Europe Crysvita Injection Sales Market Share by Type (2017-2022)
Table 56. Europe Crysvita Injection Sales by Application (2017-2022) & (K Units)
Table 57. Europe Crysvita Injection Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Crysvita Injection Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Crysvita Injection Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Crysvita Injection Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Crysvita Injection Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Crysvita Injection Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Crysvita Injection Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Crysvita Injection Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Crysvita Injection Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Crysvita Injection
Table 67. Key Market Challenges & Risks of Crysvita Injection
Table 68. Key Industry Trends of Crysvita Injection
Table 69. Crysvita Injection Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Crysvita Injection Distributors List
Table 72. Crysvita Injection Customer List
Table 73. Global Crysvita Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Crysvita Injection Sales Market Forecast by Region
Table 75. Global Crysvita Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Crysvita Injection Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Crysvita Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Crysvita Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Crysvita Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Crysvita Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Crysvita Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Crysvita Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Crysvita Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Crysvita Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Crysvita Injection Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Crysvita Injection Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Crysvita Injection Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Crysvita Injection Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Crysvita Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Crysvita Injection Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Crysvita Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Crysvita Injection Revenue Market Share Forecast by Application (2023-2028)
Table 93. Kyowa Kirin Basic Information, Crysvita Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Kyowa Kirin Crysvita Injection Product Offered
Table 95. Kyowa Kirin Crysvita Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Kyowa Kirin Main Business
Table 97. Kyowa Kirin Latest Developments
Table 98. Ultragenyx Pharmaceutical Basic Information, Crysvita Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Ultragenyx Pharmaceutical Crysvita Injection Product Offered
Table 100. Ultragenyx Pharmaceutical Crysvita Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Ultragenyx Pharmaceutical Main Business
Table 102. Ultragenyx Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Crysvita Injection
Figure 2. Crysvita Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Crysvita Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Crysvita Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Crysvita Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 10 mg/mL
Figure 10. Product Picture of 20 mg/mL
Figure 11. Product Picture of 30 mg/mL
Figure 12. Global Crysvita Injection Sales Market Share by Type in 2021
Figure 13. Global Crysvita Injection Revenue Market Share by Type (2017-2022)
Figure 14. Crysvita Injection Consumed in Children
Figure 15. Global Crysvita Injection Market: Children (2017-2022) & (K Units)
Figure 16. Crysvita Injection Consumed in Adults
Figure 17. Global Crysvita Injection Market: Adults (2017-2022) & (K Units)
Figure 18. Global Crysvita Injection Sales Market Share by Application (2017-2022)
Figure 19. Global Crysvita Injection Revenue Market Share by Application in 2021
Figure 20. Crysvita Injection Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Crysvita Injection Revenue Market Share by Company in 2021
Figure 22. Global Crysvita Injection Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Crysvita Injection Revenue Market Share by Geographic Region in 2021
Figure 24. Global Crysvita Injection Sales Market Share by Region (2017-2022)
Figure 25. Global Crysvita Injection Revenue Market Share by Country/Region in 2021
Figure 26. Americas Crysvita Injection Sales 2017-2022 (K Units)
Figure 27. Americas Crysvita Injection Revenue 2017-2022 ($ Millions)
Figure 28. APAC Crysvita Injection Sales 2017-2022 (K Units)
Figure 29. APAC Crysvita Injection Revenue 2017-2022 ($ Millions)
Figure 30. Europe Crysvita Injection Sales 2017-2022 (K Units)
Figure 31. Europe Crysvita Injection Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Crysvita Injection Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Crysvita Injection Revenue 2017-2022 ($ Millions)
Figure 34. Americas Crysvita Injection Sales Market Share by Country in 2021
Figure 35. Americas Crysvita Injection Revenue Market Share by Country in 2021
Figure 36. United States Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Crysvita Injection Sales Market Share by Region in 2021
Figure 41. APAC Crysvita Injection Revenue Market Share by Regions in 2021
Figure 42. China Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Crysvita Injection Sales Market Share by Country in 2021
Figure 49. Europe Crysvita Injection Revenue Market Share by Country in 2021
Figure 50. Germany Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Crysvita Injection Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Crysvita Injection Revenue Market Share by Country in 2021
Figure 57. Egypt Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Crysvita Injection Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Crysvita Injection in 2021
Figure 63. Manufacturing Process Analysis of Crysvita Injection
Figure 64. Industry Chain Structure of Crysvita Injection
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
